Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
12 janv. 2024 16h43 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on January 10, 2024 from the Listing...
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
05 janv. 2024 08h00 HE
|
Lifecore Biomedical, Inc.
Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for its term debt facility with Alcon and...
Lifecore Biomedical Provides Business Update
13 déc. 2023 07h30 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
20 nov. 2023 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that the U.S. Department of Justice (the “DOJ”) has declined to prosecute...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
18 oct. 2023 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on October 12, 2023 from the Listing...
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
10 oct. 2023 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
31 août 2023 07h30 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (Nasdaq: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
22 août 2023 16h06 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
22 août 2023 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on August 17, 2023 from the Listing...
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
01 juin 2023 07h15 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., June 01, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), reported...